Dr Reddy’s Lab commercially launches 2DG

2-DG manufactured by Dr Reddy’s has a purity of 99.5 per cent and is being sold commercially under the brand name 2DG.

114
Dr Reddy's

Last Updated on June 30, 2021 by The Health Master

Dr Reddy’s Laboratories announced the commercial launch of 2-deoxy-D-glucose (2-DG).

Dr Reddy’s will supply to major government as well as private hospitals across India. In the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India.

2-DG manufactured by Dr Reddy’s has a purity of 99.5 per cent and is being sold commercially under the brand name 2DG. The maximum retail price (MRP) of each sachet has been fixed at Rs 990, with a subsidized rate offered to government institutions.

2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s  2-DG is an oral drug.

Medicine Injection Doctor
picture: Pixabay

It can be administered only upon prescription and under the supervision of a qualified physician to hospitalised moderate to severe C-19 patients as an adjunct therapy to the existing standard of care. Emergency use approval for anti-C-19 therapeutic application of the drug was granted on May 1, 2021.

Dr G Satheesh Reddy, Secretary, Department of Defence (R&D) and Chairman, DRDO said, “We are pleased to have worked closely with our long-term industry partner Dr Reddy’s Laboratories, Hyderabad, for testing 2-DG as a therapeutic application in the treatment of C-19 patients. DRDO has been contributing in the fight against the C-19 pandemic with its spin-off technologies.”

Satish Reddy, Chairman, Dr Reddy’s said, “2-DG is yet another addition to our C-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and includes a vaccine. We are extremely pleased to have partnered with DRDO in our collective fight against the C-19 pandemic.”

Dr. Reddy’s Labs launches Icosapent Ethyl Capsules

Cadila Pharma launches Posaconazole to treat fungal diseases

Cipla launches Vitamin C Chewable Tablets with Gold Supplement

Glenmark launches drug to treat Pulmonary disease in UK

Alkem launches Drug for Epilepsy treatment in India

Black Fungus: Mankind Pharma launches drug for treatment

Latest Notifications: DMROA (Drugs and Magic Remedies Act)

Pharma Cos seek clarification on 5% GST on Covid drugs

Indian researchers develops ‘Smartphone test’: Diagnoses in minutes

Low Vitamin D can raise this risk from Covid by 20%

Glenmark gets USFDA nod for generic Lung cancer drug

Pfizer stops distribution of Anti Smoking Drug

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner